PURPOSE: As a result of the growing cancer incidence and the increasing trend towards chemotherapy treatment, a higher number of cancer outpatients ask for unplanned visits. This study aimed to describe the nature and magnitude of this phenomenon and to identify risk factors for repeated unplanned presentations and hospital admission. METHODS: Unplanned consultations (2,811) of 1,431 cancer patients who accessed our acute oncology clinic over a 2-year period were reviewed. Demographics, clinical variables and reason(s) for presentation were all recorded. Recurrent event survival analysis was used to evaluate the relation of potential predictors to the two outcome events repeated presentations and hospitalization. A stratified Cox proportional hazard model was used. RESULTS: Of 1,431 patients, 625 (43 %) received chemotherapy during the 90 days before the unplanned visit. Pain (27.7 %), fatigue (17.6 %), dyspnoea (13.8 %), fever (11.5 %) and gastrointestinal problems (31 %) were reported frequently. The time interval since the last chemotherapy was significantly related to the rate of repeated presentation. Two hundred and nine patients (7 %) were hospitalized after an unplanned presentation. Number of symptoms and selected toxicities, along with distance from the hospital, were all predictors for hospitalization. CONCLUSIONS: The management of unscheduled presentations of cancer outpatients is becoming crucial to avoid inappropriate selection for hospital admission and interferences with the ordinary work plan, improving quality of oncology services.
PURPOSE: As a result of the growing cancer incidence and the increasing trend towards chemotherapy treatment, a higher number of cancer outpatients ask for unplanned visits. This study aimed to describe the nature and magnitude of this phenomenon and to identify risk factors for repeated unplanned presentations and hospital admission. METHODS: Unplanned consultations (2,811) of 1,431 cancerpatients who accessed our acute oncology clinic over a 2-year period were reviewed. Demographics, clinical variables and reason(s) for presentation were all recorded. Recurrent event survival analysis was used to evaluate the relation of potential predictors to the two outcome events repeated presentations and hospitalization. A stratified Cox proportional hazard model was used. RESULTS: Of 1,431 patients, 625 (43 %) received chemotherapy during the 90 days before the unplanned visit. Pain (27.7 %), fatigue (17.6 %), dyspnoea (13.8 %), fever (11.5 %) and gastrointestinal problems (31 %) were reported frequently. The time interval since the last chemotherapy was significantly related to the rate of repeated presentation. Two hundred and nine patients (7 %) were hospitalized after an unplanned presentation. Number of symptoms and selected toxicities, along with distance from the hospital, were all predictors for hospitalization. CONCLUSIONS: The management of unscheduled presentations of cancer outpatients is becoming crucial to avoid inappropriate selection for hospital admission and interferences with the ordinary work plan, improving quality of oncology services.
Authors: Michael J Hassett; A James O'Malley; Juliana R Pakes; Joseph P Newhouse; Craig C Earle Journal: J Natl Cancer Inst Date: 2006-08-16 Impact factor: 13.506
Authors: V Morrison; B J Henderson; F Zinovieff; G Davies; R Cartmell; A Hall; S Gollins Journal: Eur J Oncol Nurs Date: 2011-05-08 Impact factor: 2.398
Authors: A Antonuzzo; E Vasile; A Sbrana; M Lucchesi; L Galli; I M Brunetti; G Musettini; A Farnesi; E Biasco; N Virgili; A Falcone; S Ricci Journal: Support Care Cancer Date: 2016-09-11 Impact factor: 3.603
Authors: Sebastiano Mercadante; Paolo Marchetti; Claudio Adile; Amanda Caruselli; Patrizia Ferrera; Andrea Costanzi; Alessandra Casuccio Journal: Support Care Cancer Date: 2018-01-08 Impact factor: 3.603
Authors: Alan Carlotto; Virginia L Hogsett; Elyse M Maiorini; Janet G Razulis; Stephen T Sonis Journal: Pharmacoeconomics Date: 2013-09 Impact factor: 4.981
Authors: Dania M van der Meer; Tracey J Weiland; Jennifer Philip; George A Jelinek; Mark Boughey; Jonathan Knott; Claudia H Marck; Jennifer L Weil; Heather P Lane; Anthony J Dowling; Anne-Maree Kelly Journal: Support Care Cancer Date: 2015-08-26 Impact factor: 3.603
Authors: Joanna-Grace M Manzano; Ruili Luo; Linda S Elting; Marina George; Maria E Suarez-Almazor Journal: J Clin Oncol Date: 2014-10-06 Impact factor: 44.544
Authors: Kristof Cuppens; Christel Oyen; Aurélie Derweduwen; Anouck Ottevaere; Walter Sermeus; Johan Vansteenkiste Journal: Support Care Cancer Date: 2016-01-27 Impact factor: 3.603